People with diabetes lost up to 34 pounds taking Eli Lilly drug, company says

helped obese patients with Type 2 diabetes lose 15% of their body weight, or about 34 pounds, on average, in a late-stage clinical trial, the drugmaker said in a news release Thursday.

— which is sold under the brand name Mounjaro for Type 2 diabetes — can be used as an effective weight loss aid. found that tirzepatide helped patients without Type 2 diabetes lose 22.5% of their body weight on average, or about 52 pounds. Patients in that trial had obesity or were overweight.

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

People with diabetes lost up to 34 pounds taking Eli Lilly drug, company saysAn Eli Lilly drug helped obese patients with Type 2 diabetes lose 15% of their body weight, or about 34 pounds, on average, in a late-stage clinical trial, the drugmaker says.
ソース: NBCNews - 🏆 10. / 86 続きを読む »

Eli Lilly stock up premarket as company’s Q1 revenue beats and it raises guidanceEli Lilly & Co. shares rose 2% premarket Thursday, after the company posted first-quarter earnings showing a revenue beat and raised its full-year guidance....
ソース: MarketWatch - 🏆 3. / 97 続きを読む »